Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Hold
752,541
0.04% 84
2026
Q1
$971K Hold
752,541
0.03% 87
2025
Q4
$1.66M Hold
752,541
0.05% 73
2025
Q3
$1.22M Hold
752,541
0.04% 73
2025
Q2
$1.95M Hold
752,541
0.07% 54
2025
Q1
$5.06M Hold
752,541
0.18% 57
2024
Q4
$5.11M Hold
752,541
0.15% 67
2024
Q3
$6.24M Hold
752,541
0.18% 71
2024
Q2
$4.77M Hold
752,541
0.15% 70
2024
Q1
$6.98M Sell
752,541
-35,413
-4% -$415K 0.22% 64
2023
Q4
$10M Sell
787,954
-200,605
-20% -$2.09M 0.37% 59
2023
Q3
$10.2M Sell
988,559
-10,803
-1% -$125K 0.32% 76
2023
Q2
$13.1M Sell
999,362
-163,932
-14% -$2.01M 0.43% 65
2023
Q1
$13M Sell
1,163,294
-458,200
-28% -$4.52M 0.43% 63
2022
Q4
$13.7M Buy
+1,621,494
New +$15.4M 0.46% 68

Other funds holding LUNG

Braidwell's LUNG Position: Q2 2026 in Review

Braidwell held its Pulmonx (LUNG) position steady in Q2 2026 at 752,541 shares worth $978K. The position accounts for 0.04% of the portfolio, ranked #84.

Braidwell first reported a position in LUNG in Q4 2022 and has held it in 15 quarters since. The position peaked at $13.7M in Q4 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Braidwell held 752,541 shares of Pulmonx worth $978K as of Q2 2026.
  • Braidwell left its Pulmonx share count unchanged in Q2 2026.
  • Pulmonx made up 0.04% of Braidwell's portfolio in Q2 2026, its #84 holding.
  • Braidwell first reported a position in Pulmonx in Q4 2022 and has held it in 15 quarters since.
  • Braidwell's Pulmonx position peaked at $13.7M in Q4 2022.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.